Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7;12(4):1307.
doi: 10.3390/jcm12041307.

The Effect of Warfarin Use on Postoperative Outcomes after Femoral Neck Surgery

Jeremy Dubin  1 , Esequiel Palmanovich  2 , Eitan Iohanes  3 , Ronen Blecher  3 , David Segal  2 , Yaron Brin  2 , Michael Drexler  3 , Ran Atzmon  3
Affiliations

The Effect of Warfarin Use on Postoperative Outcomes after Femoral Neck Surgery

Jeremy Dubin et al. J Clin Med. .

Abstract

Introduction: Anticoagulation use in the elderly is common for patients undergoing femoral neck hip surgery. However, its use presents a challenge to balance it with associated comorbidities and benefits for the patients. As such, we attempted to compare the risk factors, perioperative outcomes, and postoperative outcomes of patients who used warfarin preoperatively and patients who used therapeutic enoxaparin. Methods: From 2003 through 2014, we queried our database to determine the cohorts of patients who used warfarin preoperatively and the patients who used therapeutic enoxaparin. Risk factors included age, gender, Body Mass Index (BMI) > 30, Atrial Fibrillation (AF), Chronic Heart Failure (CHF), and Chronic Renal Failure (CRF). Postoperative outcomes were also collected at each of the patients' follow-up visits, including number of hospitalization days, delays to theatre, and mortality rate. Results: The minimum follow-up was 24 months and the average follow-up was 39 months (range: 24-60 months). In the warfarin cohort, there were 140 patients and 2055 patients in the therapeutic enoxaparin cohort. Number of hospitalization days (8.7 vs. 9.8, p = 0.02), mortality rate (58.7% vs. 71.4%, p = 0.003), and delays to theatre (1.70 vs. 2.86, p < 0.0001) were significantly longer for the anticoagulant cohort than the therapeutic enoxaparin cohort. Warfarin use best predicted number of hospitalization days (p = 0.00) and delays to theatre (p = 0.01), while CHF was the best predictor of mortality rate (p = 0.00). Postoperative complications, such as Pulmonary Embolism (PE) (p = 0.90), Deep Vein Thrombosis (DVT) (p = 0.31), and Cerebrovascular Accidents (CVA) (p = 0.72), pain levels (p = 0.95), full weight-bearing status (p = 0.08), and rehabilitation use (p = 0.34) were similar between the cohorts. Conclusion: Warfarin use is associated with increased number of hospitalization days and delays to theatre, but does not affect the postoperative outcome, including DVT, CVA, and pain levels compared to therapeutic enoxaparin use. Warfarin use proved to be the best predictor of hospitalization days and delays to theatre while CHF predicted mortality rate.

Keywords: anticoagulation; femoral neck; hospitalization days; mortality rate; warfarin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Inclusion criteria for patient selection.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention Injury Prevention and Control: Hip Fractures among Older Adults. [(accessed on 24 October 2019)]; Available online: http://www.cdc.gov/HomeandRecreationalSafety/Falls/adulthipfx.html.
    1. Edelmuth S.V.C.L., Sorio G.N., Sprovieri F.A.A., Gali J.C., Peron S.F. Comorbidities, clinical intercurrences, and factors associated with mortality in elderly patients admitted for a hip fracture. Rev. Bras. De Ortop. 2018;53:543–551. doi: 10.1016/j.rbo.2017.07.009. - DOI - PMC - PubMed
    1. Maccagnano G., Notarnicola A., Pesce V., Mudoni S., Tafuri S., Moretti B. The prevalence of fragility fractures in a population of a region of southern Italy affected by thyroid disorders. BioMed Res. Int. 2016;2016:6017165. doi: 10.1155/2016/6017165. - DOI - PMC - PubMed
    1. Notarnicola A., Maccagnano G., Tafuri S., Moretti L., Laviola L., Moretti B. Epidemiology of diabetes mellitus in the fragility fracture population of a region of Southern Italy. J. Biol. Regul. Homeost. Agents. 2016;30:297–302. - PubMed
    1. Shahpouri M.M., Mousavi S., Khorvash F., Mousavi S.M., Hoseini T. Anticoagulant therapy for ischemic stroke: A review of literature. J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci. 2012;17:396. - PMC - PubMed